## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as stated in the abstract; no access to methods, figures, tables, or supplementary data
- **Shared manuscript claim summary** The authors report the crystal structure of a GH134 β-mannanase from *Aspergillus nidulans* (AnGH134) at 1.75 Å resolution, propose an inverting catalytic mechanism with Glu43 and Asp55 as catalytic residues, describe an extended substrate-binding groove with functional contributions from groove-exit and C-terminal residues, and demonstrate that N-terminal CBM10 fusion improves catalytic efficiency and thermal stability while C-terminal fusion is detrimental.
- **Visible evidence base** Abstract text only; no structural coordinates, kinetic data, mutagenesis results, MD simulation details, or stability measurements are visible
- **Missing materials affecting confidence** Full manuscript, all figures and tables, methods section, crystallographic statistics, kinetic parameters, thermostability data, MD simulation protocols, and construct design details

## Reviewer
- **Overall assessment** The abstract presents a potentially useful structure-function study of a GH134 mannanase with an engineering outcome of practical interest for the agrochemical and food industries. The structural work appears to be of reasonable quality based on the reported resolution, and the combination of crystallography, docking, mutagenesis, and MD simulation is methodologically appropriate. However, the abstract alone does not provide sufficient quantitative evidence to evaluate the strength of the catalytic mechanism proposal, the functional significance of the identified residues, or the magnitude of the reported activity and stability improvements. The engineering claim, while interesting, lacks quantitative context that would allow assessment of its practical relevance.

- **Who would be interested in the results, and why** Researchers in glycoside hydrolase enzymology, particularly those working on GH134 family enzymes and mannan-degrading biocatalysts; industrial enzymologists interested in enzyme engineering for biomass conversion; and food scientists developing manno-oligosaccharide production processes. The structural data may also be of interest to the broader carbohydrate-active enzyme community.

- **Major strengths** 
  The study combines multiple complementary techniques (crystallography, docking, mutagenesis, MD simulation, and fusion engineering) in a single investigation. The reported 1.75 Å resolution suggests a high-quality crystal structure. The identification of a lysozyme-like fold in a GH134 enzyme from a new source adds to the structural coverage of this family. The differential effect of N-terminal versus C-terminal CBM10 fusion is a non-obvious finding with potential practical implications.

- **Major Concerns**

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** "supports an inverting catalytic mechanism with Glu43 and Asp55 as the putative catalytic residues"
- **Evidence pointer** Abstract; location not provided
- **Concern** The abstract states that the structure "supports" an inverting mechanism with Glu43 and Asp55 as catalytic residues, but no direct evidence is presented. The abstract mentions docking, mutational, and MD analyses, but does not specify which mutations were made, what their kinetic consequences were, or how the MD simulations informed the mechanistic assignment. The term "putative" appropriately hedges the catalytic residue assignment, but the mechanistic claim of "inverting" requires experimental validation (e.g., product stereochemistry analysis) that is not described.
- **Why it matters** The catalytic mechanism is a central claim of the paper. An incorrect mechanistic assignment would mislead subsequent engineering efforts and the broader GH134 community. The distinction between retaining and inverting mechanisms has direct implications for how the enzyme is classified and engineered.
- **Resolution test** The full manuscript must provide product stereochemistry data (e.g., NMR or enzyme-coupled assays) demonstrating inversion, or clearly state if the inverting assignment is inferred solely from structural analogy. Mutational data must show that Glu43 and Asp55 variants abolish or substantially reduce activity, with quantitative kinetic parameters reported.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Quantitative support
- **Claim pointer** "N-terminal fusion of CBM10 enhanced catalytic efficiency and thermal stability, whereas C-terminal fusion was detrimental"
- **Evidence pointer** Abstract; location not provided
- **Concern** The abstract reports that N-terminal CBM10 fusion enhanced catalytic efficiency and thermal stability, but provides no quantitative values. No kinetic parameters (kcat, Km, kcat/Km) for the wild-type versus fusion constructs are given, and no thermal stability data (Tm values, half-life at a given temperature, or residual activity profiles) are reported. The magnitude of the enhancement and the degree of detriment are therefore unknown.
- **Why it matters** The engineering outcome is the primary applied contribution of this work. Without quantitative context, readers cannot judge whether the improvement is marginal or substantial, whether it is statistically significant, or whether it is practically meaningful for industrial applications. The claim as stated is not falsifiable from the abstract alone.
- **Resolution test** The full manuscript must report kinetic parameters with errors and statistical comparisons for wild-type and both fusion constructs, and thermal stability data (e.g., Tm from differential scanning fluorimetry or circular dichroism, or activity retention over time at defined temperatures) with appropriate replicates.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** No
- **Axis** Functional attribution
- **Claim pointer** "groove-exit residues and the C-terminal region contribute to productive catalysis"
- **Evidence pointer** Abstract; location not provided
- **Concern** The abstract attributes functional importance to "groove-exit residues" and the "C-terminal region" based on docking, mutational, and MD analyses, but does not specify which residues were mutated, what the observed effects were, or how the MD simulations supported this conclusion. The phrase "contribute to productive catalysis" is vague and could encompass effects on substrate binding, processivity, product release, or overall stability.
- **Why it matters** This claim is the structural rationale for the subsequent engineering strategy. If the functional attribution is not clearly established with specific residue-level data, the logic connecting structure to engineering is weakened.
- **Resolution test** The full manuscript must identify the specific residues involved, present their mutational effects on kinetic parameters, and show MD-derived evidence (e.g., substrate trajectory analyses, interaction energy calculations) that supports the proposed functional roles.

- **Minor Comments**

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Substrate specificity statement
- **Evidence pointer** Abstract, first sentence
- **Issue** The abstract states that mannans are "abundant plant hemicelluloses" and that endo-β-mannanases convert them into "functional manno-oligosaccharides," but does not specify the substrate scope of AnGH134 beyond locust bean gum. It is unclear whether the enzyme acts on other mannan substrates (e.g., konjac glucomannan, ivory nut mannan) and whether the reported activity is specific to β-1,4-mannan backbones.
- **Required correction** Clarify the substrate specificity of AnGH134 in the abstract, or state explicitly that only locust bean gum was tested.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Completeness
- **Affected element** CBM10 fusion rationale
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract does not explain why CBM10 was chosen for fusion. CBM10 is a family 10 carbohydrate-binding module, but its known ligand specificity and the rationale for fusing it to a mannanase are not stated.
- **Required correction** Add a brief statement in the abstract or introduction explaining the choice of CBM10 and its expected function (e.g., cellulose-binding or mannan-binding properties).

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Terminology
- **Affected element** "lysozyme-like fold"
- **Evidence pointer** Abstract; location not provided
- **Issue** The term "lysozyme-like fold" is used without further qualification. GH134 enzymes have been described as having a distorted (β/α)8 barrel or a lysozyme-like fold in previous literature, but the abstract does not specify the structural details or how the AnGH134 fold compares to previously characterized GH134 members.
- **Required correction** Provide a brief structural description (e.g., number of β-strands, α-helices, or the specific fold classification) or cite the relevant structural comparison in the abstract.

- **Technical failings that need to be addressed before the case is established** R1-M1 and R1-M2 are the primary technical concerns. The catalytic mechanism claim requires direct experimental evidence, and the engineering claims require quantitative kinetic and stability data. R1-M3 requires residue-level specificity to be fully resolved.

- **Assessment against Nature-style criteria** 
  - **Originality**: Moderate. Structural characterization of a new GH134 member adds incremental knowledge, but the fold is described as conserved and the catalytic mechanism is proposed by analogy. The engineering approach is not conceptually novel, though the differential N- versus C-terminal fusion effect is a potentially interesting observation.
  - **Scientific importance**: Moderate. GH134 mannanases are of interest to a specialized community, and the engineering outcome may have applied value, but the abstract does not demonstrate a conceptual advance that would elevate the importance beyond a solid structure-function study.
  - **Interdisciplinary readership**: Limited. The work is primarily of interest to glycoside hydrolase enzymologists and industrial enzyme engineers. The abstract does not frame the findings in a way that would attract a broader readership.
  - **Technical soundness**: Cannot be fully assessed from the abstract. The combination of methods is appropriate, and the reported resolution is good, but the absence of quantitative data prevents evaluation of the robustness of the conclusions.
  - **Readability for nonspecialists**: The abstract is reasonably clear but uses field-specific terminology (e.g., "GH134," "CBM10," "lysozyme-like fold") without sufficient context for a general scientific audience.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents a plausible and potentially useful study, but the central mechanistic and engineering claims lack the quantitative and experimental detail required for evaluation. A full assessment requires the complete manuscript, including crystallographic statistics, kinetic data, mutational analysis, MD simulation details, and stability measurements. If the full data support the claims as stated, the work could be a solid contribution to the applied enzymology literature, though its scope and significance are more aligned with a specialized journal than with a broad-impact venue.